Alka Chaubey - 11 Sep 2025 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role: Chief Medical Officer
Signature: /s/ Jonathan V. Dixon, Attorney-in-Fact
Issuer symbol: BNGO
Transactions as of: 11 Sep 2025
Net transactions value: -$207
Form type: 4
Filing time: 12 Sep 2025, 16:49:08 UTC
Previous filing: 03 Jun 2025
Next filing: 04 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Chaubey Alka	Chief Medical Officer	C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO	/s/ Jonathan V. Dixon, Attorney-in-Fact	12 Sep 2025	0001821605

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BNGO	Common Stock	Tax liability	$207	-51	-7.2%	$4.06	662	11 Sep 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person is reporting the withholding by the Issuer an aggregate of 51 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.